Futura Medical plc (AIM:FUM)

Market Cap	6.48M
Revenue (ttm)	7.93M
Net Income (ttm)	-6.29M
Shares Out	581.12M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,325,220
Average Volume	11,846,368
Open	1.244
Previous Close	1.150
Day's Range	1.100 - 1.253
52-Week Range	0.989 - 32.562
Beta	0.50
RSI	38.74
Earnings Date	Dec 12, 2025

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM